C. A. Stiller, International patterns of cancer incidence in adolescents, Cancer Treatment Reviews, vol.33, issue.7, pp.631-645, 2007.
DOI : 10.1016/j.ctrv.2007.01.001

A. J. Mutsaers and C. R. Walkley, Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?, Bone, vol.62, pp.56-63, 2014.
DOI : 10.1016/j.bone.2014.02.003

M. S. Isakoff, S. S. Bielack, P. Meltzer, and R. Gorlick, Osteosarcoma: Current Treatment and a Collaborative Pathway to Success, Journal of Clinical Oncology, vol.33, issue.27, pp.3029-30354895, 2015.
DOI : 10.1200/JCO.2014.59.4895
URL : http://europepmc.org/articles/pmc4979196?pdf=render

J. Mei, X. Z. Zhu, Z. Y. Wang, and X. S. Cai, Functional outcomes and quality of life in patients with osteosarcoma treated with amputation versus limb-salvage surgery: a systematic review and meta-analysis, Archives of Orthopaedic and Trauma Surgery, vol.38, issue.11, pp.1507-1516, 2014.
DOI : 10.1080/13577140120099173

A. L. Kolodkin, D. J. Matthes, and C. S. Goodman, The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules, Cell, vol.75, issue.7, pp.1389-1399, 1993.
DOI : 10.1016/0092-8674(93)90625-Z

Y. Luo, D. Raible, and J. A. Raper, Collapsin: A protein in brain that induces the collapse and paralysis of neuronal growth cones, Cell, vol.75, issue.2, pp.217-227, 1993.
DOI : 10.1016/0092-8674(93)80064-L

R. H. Adams, M. Lohrum, A. Klostermann, H. Betz, and A. W. Puschel, The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing, The EMBO Journal, vol.16, issue.20, pp.6077-60866077, 1997.
DOI : 10.1093/emboj/16.20.6077

A. Klostermann, M. Lohrum, R. H. Adams, and A. W. Puschel, The Chemorepulsive Activity of the Axonal Guidance Signal Semaphorin D Requires Dimerization, Journal of Biological Chemistry, vol.14, issue.13, pp.7326-7331, 1998.
DOI : 10.1126/science.7973638

A. Catalano, Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function, Blood, vol.107, issue.8, pp.3321-3329, 2005.
DOI : 10.1182/blood-2005-06-2445
URL : http://www.bloodjournal.org/content/bloodjournal/107/8/3321.full.pdf

A. B. Wehner, Semaphorin 3A is a retrograde cell death signal in developing sympathetic neurons, Development, vol.143, issue.9, pp.1560-1570134627, 2016.
DOI : 10.1242/dev.134627

G. A. Schwarting, D. Raitcheva, J. E. Crandall, C. Burkhardt, and A. W. Puschel, Semaphorin 3A-mediated axon guidance regulates convergence and targeting of P2 odorant receptor axons, European Journal of Neuroscience, vol.93, issue.7, pp.1800-1810, 2004.
DOI : 10.1007/s004180050175

G. A. Schwarting, Semaphorin 3A Is Required for Guidance of Olfactory Axons in Mice, The Journal of Neuroscience, vol.20, issue.20, pp.7691-7697, 2000.
DOI : 10.1523/JNEUROSCI.20-20-07691.2000

S. Y. Fu, K. Sharma, Y. Luo, J. A. Raper, and E. Frank, SEMA3A regulates developing sensory projections in the chicken spinal cord, Journal of Neurobiology, vol.361, issue.4, pp.227-236, 2000.
DOI : 10.1101/SQB.1990.055.01.045

V. D. Dontchev and P. C. Letourneau, Nerve Growth Factor and Semaphorin 3A Signaling Pathways Interact in Regulating Sensory Neuronal Growth Cone Motility, The Journal of Neuroscience, vol.22, issue.15, pp.6659-6669, 2002.
DOI : 10.1523/JNEUROSCI.22-15-06659.2002

L. Tamagnone, Plexins Are a Large Family of Receptors for Transmembrane, Secreted, and GPI-Anchored Semaphorins in Vertebrates, Cell, vol.99, issue.1, pp.71-80, 1999.
DOI : 10.1016/S0092-8674(00)80063-X

T. Takahashi, Plexin-Neuropilin-1 Complexes Form Functional Semaphorin-3A Receptors, Cell, vol.99, issue.1, pp.59-69, 1999.
DOI : 10.1016/S0092-8674(00)80062-8
URL : https://doi.org/10.1016/s0092-8674(00)80062-8

C. Nasarre, Neuropilin-2 acts as a modulator of Sema3A-dependent glioma cell migration, Cell Adhesion & Migration, vol.22, issue.4, pp.383-389, 2009.
DOI : 10.1038/nrc2404

P. Nasarre, R. M. Gemmill, and H. A. Drabkin, The emerging role of class-3 semaphorins and their neuropilin receptors in oncology, Onco Targets Ther, vol.7, pp.1663-1687, 2014.

M. W. Muller, Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer, International Journal of Cancer, vol.26, issue.11, pp.2421-243322949, 2007.
DOI : 10.1002/ijc.22949

H. Zhou, A. Wu, W. Fu, Z. Lv, and Z. Zhang, Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer, Oncology Letters, vol.7, issue.5, pp.1395-1400, 2014.
DOI : 10.3892/ol.2014.1920

H. Pan and R. E. Bachelder, Autocrine Semaphorin3A stimulates eukaryotic initiation factor 4E-dependent RhoA translation in breast tumor cells, Experimental Cell Research, vol.316, issue.17, pp.2825-2832, 2010.
DOI : 10.1016/j.yexcr.2010.07.012
URL : http://europepmc.org/articles/pmc3723326?pdf=render

R. Mishra, Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis, Oncogene, vol.63, issue.12, pp.1584-159579, 2015.
DOI : 10.1007/s10549-009-0674-9

J. G. Herman and G. Meadows, Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells, International Journal of Oncology, vol.30, pp.1231-1238, 2007.
DOI : 10.3892/ijo.30.5.1231

H. Zhu, H. Cai, M. Tang, and J. Tang, Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis, Clinical and Translational Oncology, vol.68, issue.8, pp.732-738, 2014.
DOI : 10.1158/0008-5472.CAN-07-6601

A. Boro, Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma, Am J Transl Res, vol.7, pp.640-653, 2015.

T. Ji, Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma, Molecular Cancer, vol.265, issue.1, 2015.
DOI : 10.1038/onc.2010.160

E. K. Messersmith, Sernaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord, Neuron, vol.14, issue.5, pp.949-959, 1995.
DOI : 10.1016/0896-6273(95)90333-X

M. Hayashi, Osteoprotection by semaphorin 3A, Nature, vol.102, issue.7396, pp.69-74, 2012.
DOI : 10.1073/pnas.0506580102

R. Xu, Semaphorin 3A, Cell Adhesion & Migration, vol.3, issue.1, pp.5-1027752, 2014.
DOI : 10.1007/s001980200050
URL : http://www.tandfonline.com/doi/pdf/10.4161/cam.27752?needAccess=true

C. Gomez, Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation. Developmental dynamics: an official publication of the American Association of Anatomists, pp.393-40320512, 2005.
URL : https://hal.archives-ouvertes.fr/ujm-00132076

L. Verlinden, Nrp2 deficiency leads to trabecular bone loss and is accompanied by enhanced osteoclast and reduced osteoblast numbers, Bone, vol.55, issue.2, pp.465-475, 2013.
DOI : 10.1016/j.bone.2013.03.023

Y. Li, L. Yang, S. He, and J. Hu, The effect of semaphorin 3A on fracture healing in osteoporotic rats, J Orthop Sci, 2015.

K. Mori, Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANKpositive Saos-2 human osteosarcoma cells, Oncol Rep, vol.18, pp.1365-1371, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00667508

S. J. Kim, Imaging findings of extrapulmonary metastases of osteosarcoma, Clinical Imaging, vol.28, issue.4, pp.291-300, 1016.
DOI : 10.1016/S0899-7071(03)00206-7

Y. Li, L. Yang, S. He, and J. Hu, The effect of semaphorin 3A on fracture healing in osteoporotic rats, J Orthop Sci, vol.20, pp.1114-1121, 2015.

Z. Li, The Role of Semaphorin 3A in Bone Remodeling, Frontiers in Cellular Neuroscience, vol.15, issue.40, p.40, 2017.
DOI : 10.1101/gad.862101

A. Alfranca, Bone microenvironment signals in osteosarcoma development, Cellular and Molecular Life Sciences, vol.128, issue.2, pp.3097-3113, 1918.
DOI : 10.1002/ijc.25331

D. Branstetter, RANK and RANK ligand expression in primary human osteosarcoma, Journal of Bone Oncology, vol.4, issue.3, pp.59-68002, 2015.
DOI : 10.1016/j.jbo.2015.06.002
URL : https://doi.org/10.1016/j.jbo.2015.06.002

V. Krishnan, H. U. Bryant, and O. A. Macdougald, Regulation of bone mass by Wnt signaling, Journal of Clinical Investigation, vol.116, issue.5, pp.1202-1209, 2006.
DOI : 10.1172/JCI28551

T. Akiyama, C. R. Dass, and P. Choong, Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway, Molecular Cancer Therapeutics, vol.7, issue.11, pp.3461-3469, 2008.
DOI : 10.1158/1535-7163.MCT-08-0530
URL : http://mct.aacrjournals.org/content/molcanther/7/11/3461.full.pdf

A. Casazza, Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.31, issue.4, pp.741-749, 2011.
DOI : 10.1161/ATVBAHA.110.211920

G. Chakraborty, S. Kumar, R. Mishra, T. V. Patil, and G. C. Kundu, Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model, PLoS ONE, vol.9, issue.3, 2012.
DOI : 10.1371/journal.pone.0033633.s007
URL : https://doi.org/10.1371/journal.pone.0033633

G. M. Campbell and A. Sophocleous, Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies, BoneKEy Reports, vol.3, issue.564, 2014.
DOI : 10.1038/bonekey.2014.59

R. G. Erben and M. Glosmann, Histomorphometry in Rodents, Methods Mol Biol, vol.816101007, pp.279-303978, 2012.
DOI : 10.1007/978-1-61779-415-5_19

G. R. Nakayama, M. C. Caton, M. P. Nova, and . Parandoosh, Assessment of the Alamar Blue assay for cellular growth and viability in vitro, Journal of Immunological Methods, vol.204, issue.2, pp.205-208, 1997.
DOI : 10.1016/S0022-1759(97)00043-4

S. E. Taylor, M. Shah, and I. Orriss, Generation of rodent and human osteoblasts, BoneKEy Reports, vol.3, issue.585, p.80, 2014.
DOI : 10.1038/bonekey.2014.80

A. I. Idris, J. Rojas, I. R. Greig, R. J. Van-'t-hof, and S. H. Ralston, Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro, Calcified Tissue International, vol.276, issue.3, pp.191-201, 2008.
DOI : 10.1007/s00223-008-9104-y

A. Sophocleous, Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis, Journal of Biological Chemistry, vol.382, issue.36, pp.22049-22060, 2015.
DOI : 10.1016/j.bone.2006.09.002

S. Marino, J. G. Logan, D. Mellis, and M. Capulli, Generation and culture of osteoclasts, BoneKEy Reports, vol.3, issue.570, p.65, 2014.
DOI : 10.1038/bonekey.2014.65